论文信息 - A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population - 字舞流文

A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population

R. Gish | J. Lau | T. Schluep | S. Locarnini | E. Gane | C. Ferrari | B. Given | C. Schwabe | J. Hamilton | Ching‐lung Lai